A Retrospective Cohort Study on Rehospitalization following Expanded Criteria Donor Kidney Transplantation

Table 2

Results of the 1- and 2-year Andersen–Gill (AG) model.

Variable	1 yr HR	1 yr 95% CI	1 yr value	2 yr HR	2 yr 95% CI	2 yr value
ECD	1.43	[1.14,1.79]	0.002	1.32	[1.06, 1.65]	∗0.015
Years on dialysis	1.04	[1, 1.07]	0.03	1.03	[0.998, 1.07]	0.065
Admissions 180 d before transplant	1.18	[1.02,1.38]	0.029	1.22	[1.06, 1.41]	∗0.005
Race black	1.23	[0.912, 1.67]	0.173	1.22	[0.915, 1.63]	0.176
Race hispanic	1.35	[0.993, 1.83]	0.055	1.32	[0.975, 1.79]	0.072
Age >65	1.24	[0.924, 1.66]	0.153	1.22	[0.924, 1.61]	0.16
ESRD, FSGS, or IgA	0.734	[0.491,1.1]	0.131	0.75	[0.527, 1.07]	0.109
ESRD membranous, MPGN, or lupus	0.764	[0.508, 1.15]	0.196	0.752	[0.534, 1.06]	0.104
Basiliximab	0.89	[0.654, 1.21]	0.461	0.909	[0.68, 1.21]	0.515
MMF	1.23	[0.85,1.79]	0.271	1.15	[0.827, 1.59]	0.41
Sirolimus	0.945	[0.715, 1.25]	0.689	0.929	[0.712, 1.21]	0.589
Tacrolimus	2.12	[0.637, 7.02]	0.221	1	[0.56, 1.79]	0.996
CDC	1.02	[0.764, 1.36]	0.896	1.07	[0.796, 1.43]	0.667
HCV	1.24	[0.763, 2.02]	0.384	1.4	[0.865, 2.26]	0.171
BMI	1.01	[0.99,1.02]	0.433	1.01	[0.996, 1.03]	0.139
CIT	1	[1, 1]	0.933	1	[1, 1]	0.985
WIT	1	[0.995, 1.01]	0.398	1	[0.993, 1.01]	0.721
Charlson Index	1.03	[0.981, 1.08]	0.221	1.04	[0.991, 1.08]	0.114
Length of stay	1.01	[1, 1.01]	0.063	1.01	[0.999, 1.01]	0.092
Surgeon 1	1.13	[0.739, 1.72]	0.580	1.11	[0.748, 1.65]	0.599
Surgeon 2	1.2	[0.765, 1.87]	0.432	1.16	[0.745, 1.8]	0.514
Surgeon 3	0.915	[0.595, 1.41]	0.687	0.883	[0.559, 1.4]	0.595
Surgeon 4	1.2	[0.807, 1.77]	0.372	1.24	[0.856, 1.81]	0.254
Surgeon 5	0.906	[0.554, 1.48]	0.695	0.879	[0.558, 1.38]	0.577
Surgeon 6	1.23	[0.691, 2.2]	0.479	1.16	[0.584, 1.97]	0.584

values<0.05. HR = hazard ratio; CI = confidence interval; ECD = expanded criteria donor kidney; CIT = cold ischemia time; WIT = warm ischemia time.